Acorda, Elan sales and marketing update

Acorda said the wholesale acquisition cost (WAC) of Ampyra dalfampridine (formerly Fampridine-SR) will be $1,056 per 30-day supply, with an annual cost of $12,850. The company expects to launch Ampy...